Victoria-Jungfrau Collection AG has been acquired by AEVIS Holding SA
The shareholders of Victoria Jungfrau Collection AG, (VJC) the Swiss group of luxury hotels, received a public takeover offer from AEVIS Holding SA (AEVIS), a Swiss investment group focusing on the healthcare sector, acquiring a majority shareholding for US$69.5 million.
The Victoria-Jungfrau Collection AG is a small but exclusive hotel group with a unique portfolio of luxury five-star hotels of long standing. Other hotels of the group include The Victoria-Jungfrau Grand Hotel & Spa in Interlaken, the Palace Luzern on the shores of Lake Lucerne, the Eden au Lac in Zurich and the renowned Bellevue Palace in Bern.
AEVIS invests in the healthcare, life sciences, services and lifestyle sectors. The firm wishes to progressively develop new sectors of activity, amongst others in the sector of outpatient surgical centers, radiology and dental medicine and hotel or hotel related activities.
Oaklins' team in Switzerland was mandated by the board of VJC to assist in the assessment of the bids from a financial perspective. It was imperative to focus on the interests of the company and the shareholders and to achieve a fair price, while taking into consideration the strategic plans for the target of each bidder. The competitive situation of two bidders resulted in a stepwise increase of the price.
Talk to the deal team
Related deals
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn more